Parkinson’s UK funding 2 research projects into risk, protective factors
Parkinson’s UK is funding two new basic research projects at the University of Edinburgh, in Scotland, that have as…
Articles by Margarida Maia, PhD
Signs of Parkinson’s may be visible long before diagnosis
It may be possible to spot telltale signs of Parkinson’s disease on positron emission tomography (PET) scans as early…
Cure Parkinson’s funds preclinical research for drug repurposing
Cure Parkinson’s is funding preclinical research that intends to provide the evidence needed to determine whether three existing compounds…
High-dose risvodetinib effective, safe for Parkinson’s, new data show
A once-daily 200 mg dose of Inhibikase Therapeutics’ risvodetinib — an oral medication previously called IkT-148009, now undergoing…
IRLAB ramps up for mesdopetam Phase 3 program in Parkinson’s
IRLAB Therapeutics is taking steps in preparation for a Phase 3 clinical program of mesdopetam, an experimental medicine for…
Loneliness may increase person’s risk of Parkinson’s within 15 years
Loneliness raises a person’s risk of developing Parkinson’s disease within 15 years, a long-term study of nearly half a…
NIH grant to Vincere supports work into way of helping mitochondria
Vincere Biosciences has been given $700,000 in seed funding by the National Institutes of Health (NIH) to advance…
Fruit-fly study on circadian clock offers clues about Parkinson’s risk
Interfering with the circadian clock, or the body’s internal clock, may make dopaminergic neurons — the nerve cells that become…
Freezing of gait more likely to occur with long-term levodopa use
Patients who are on long-term levodopa to treat Parkinson’s disease are more likely to experience self-reported freezing of…
More evidence needed to support link between ADHD, Parkinson’s
While it appears that people with attention deficit hyperactivity disorder (ADHD) are more likely to develop Parkinson’s disease later…